Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution

Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coron...

Full description

Bibliographic Details
Main Authors: Abedi, M. (Author), Abele, D. (Author), Basermann, A. (Author), Binder, S. (Author), Gilg, J. (Author), Häberle, M. (Author), Khailaie, S. (Author), Kleinert, J. (Author), Klitz, M. (Author), Koslow, W. (Author), Kühn, M.J (Author), Meyer-Hermann, M. (Author), Mitra, T. (Author), Plötzke, L. (Author), Rack, K. (Author), Siggel, M. (Author), Spataro, L. (Author), Spinner, C.D (Author), Stecher, M. (Author), Zhu, X.X (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2021
Subjects:
age
Online Access:View Fulltext in Publisher
LEADER 04625nam a2201141Ia 4500
001 10.1016-j.mbs.2021.108648
008 220427s2021 CNT 000 0 und d
020 |a 00255564 (ISSN) 
245 1 0 |a Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution 
260 0 |b Elsevier Inc.  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.mbs.2021.108648 
520 3 |a Non-pharmaceutical interventions (NPIs) are important to mitigate the spread of infectious diseases as long as no vaccination or outstanding medical treatments are available. We assess the effectiveness of the sets of non-pharmaceutical interventions that were in place during the course of the Coronavirus disease 2019 (Covid-19) pandemic in Germany. Our results are based on hybrid models, combining SIR-type models on local scales with spatial resolution. In order to account for the age-dependence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we include realistic prepandemic and recently recorded contact patterns between age groups. The implementation of non-pharmaceutical interventions will occur on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. In order to account for spatial heterogeneity, we use a graph approach and we include high-quality information on commuting activities combined with traveling information from social networks. The remaining uncertainty will be accounted for by a large number of randomized simulation runs. Based on the derived factors for the effectiveness of different non-pharmaceutical interventions over the past months, we provide different forecast scenarios for the upcoming time. © 2021 
650 0 4 |a age 
650 0 4 |a Age Factors 
650 0 4 |a Article 
650 0 4 |a assessment method 
650 0 4 |a asymptomatic infection 
650 0 4 |a communicable disease control 
650 0 4 |a Communicable Disease Control 
650 0 4 |a Coronavirus 
650 0 4 |a Coronavirus disease 
650 0 4 |a coronavirus disease 2019 
650 0 4 |a Covid-19 
650 0 4 |a COVID-19 
650 0 4 |a COVID-19 
650 0 4 |a death 
650 0 4 |a Demographic information 
650 0 4 |a demographic trend 
650 0 4 |a demography 
650 0 4 |a disease spread 
650 0 4 |a disease transmission 
650 0 4 |a Diseases 
650 0 4 |a epidemic 
650 0 4 |a Forecast 
650 0 4 |a Germany 
650 0 4 |a Germany 
650 0 4 |a Germany 
650 0 4 |a High quality information 
650 0 4 |a hospitalization 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Image resolution 
650 0 4 |a incidence 
650 0 4 |a infection rate 
650 0 4 |a Infectious disease 
650 0 4 |a intensive care 
650 0 4 |a intensive care unit 
650 0 4 |a lockdown 
650 0 4 |a mathematical model 
650 0 4 |a Medical treatment 
650 0 4 |a mitigation 
650 0 4 |a Mitigation 
650 0 4 |a Models, Statistical 
650 0 4 |a Non-pharmaceutical interventions 
650 0 4 |a Non-pharmaceutical interventions 
650 0 4 |a pandemic 
650 0 4 |a patient isolation 
650 0 4 |a polymerase chain reaction 
650 0 4 |a prediction 
650 0 4 |a prediction 
650 0 4 |a prevention and control 
650 0 4 |a procedures 
650 0 4 |a quarantine 
650 0 4 |a SARS coronavirus 
650 0 4 |a SARS-CoV-2 
650 0 4 |a season 
650 0 4 |a Severe acute respiratory syndrome coronavirus 
650 0 4 |a Severe acute respiratory syndrome coronavirus 2 
650 0 4 |a simulation 
650 0 4 |a Social Network Analysis 
650 0 4 |a spatial analysis 
650 0 4 |a Spatial Analysis 
650 0 4 |a Spatial heterogeneity 
650 0 4 |a Spatial resolution 
650 0 4 |a spatiotemporal analysis 
650 0 4 |a statistical model 
650 0 4 |a vaccination 
700 1 |a Abedi, M.  |e author 
700 1 |a Abele, D.  |e author 
700 1 |a Basermann, A.  |e author 
700 1 |a Binder, S.  |e author 
700 1 |a Gilg, J.  |e author 
700 1 |a Häberle, M.  |e author 
700 1 |a Khailaie, S.  |e author 
700 1 |a Kleinert, J.  |e author 
700 1 |a Klitz, M.  |e author 
700 1 |a Koslow, W.  |e author 
700 1 |a Kühn, M.J.  |e author 
700 1 |a Meyer-Hermann, M.  |e author 
700 1 |a Mitra, T.  |e author 
700 1 |a Plötzke, L.  |e author 
700 1 |a Rack, K.  |e author 
700 1 |a Siggel, M.  |e author 
700 1 |a Spataro, L.  |e author 
700 1 |a Spinner, C.D.  |e author 
700 1 |a Stecher, M.  |e author 
700 1 |a Zhu, X.X.  |e author 
773 |t Mathematical Biosciences